The 2nd World Precision Medicine Summit (China) 2017 was hold in Shanghai, 1st, December to 2nd, December, under the theme of “Looking Insight into Precision Medicine Development and Technology Advancement”. The WPMSC 2017 brought together senior executives from Government, academy, hospitals, big pharmas, life sciences & biotech companies, CROs, VCPEs to exchange in-depth views concerning regulatory updates in precision medicine , investment opportunities, big data and advanced genetic testing & IVD technologies, biobank & cohort study, cancer precision therapeutics ,cell immunotherapy and new drug discovery.
Biologix showed the CryoKING complete biobanking solutions at Booth A 19, and shared its latest biobanking solutions with leading figures on precision medical trends.
CryoKING, a brand by Biologix, holds 3 core biobanking services which are the integrated biobanking designs, bibaking supplies and comprehensive trainings.
CryoKING focus on the standardization, formalization and digitalization of biobank. Its advantage is based on upstream industry, research and market integration, covering the downstream industry to offer complete and one-stop solution for modern biobank. Its overall technology is on the top level in this industry. With the professional design, advanced techniques, safe and efficient management, CryoKING covers every phase of biobanking and offers complete biobanking service.
In 2015, US President Obama launched the Precision Medicine Initiative and precision medicine has become the spotlight of global healthcare industry. Meanwhile, Chinese Precision Medicine Plan has been included in the 13th FYP for national major science & technology specific projects. Government is expected to invest 60 billion RMB to boost Chinese precision medicine industry development before 2030. Stimulated by favorable policies and funding environment, and with the rapid technology advancements of genetic testing, biochip, cell immunotherapy, IVD, liquid biopsy, anti-body drugs R&D, big data and inspiring research breakthroughs, Chinese precision medicine industry is embracing new development opportunities.
Recent years, Biologix has been constantly increasing the input on scientific R & D, and strengthening self-independent innovation in CryoKING complete biobanking solutions Presently, Biologix has several PCT international patents, invention model patents, utility model patents and software copyrights. Due to the continuous technological innovation, CryoKING has enriched its complete biobanking solutions and keeps competitive in biobanking field. Now, CryoKING complete biobanking solutions are widely used in research institutes, hospital, universities and other institutes to assist them in perfecting the biobanking build and management!